Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioTech Development in Sweden AB
AB
Active
Org 5566619077
Skaldevägen 17, 167 71
Bromma
Computer programming activities
·
NACE 6210
Est. 2004 · 22 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Computer programming activities
/
BioTech Development in Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
2026: 0M
0M
2026
EBITDA
SEK millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
2026: 0M
0M
2026
Income statement
SEK thousands
Item
2026
2025
2024
2023
2022
Revenue
0
0
170
600
470
Staff expenses
—
−0
−19
—
—
EBITDA
−17
−23
134
572
460
Depreciation & amort.
—
—
—
—
—
EBIT
−17
−23
134
572
460
Net financials
0
11
6
−0
223
Profit before tax
7
−12
140
572
568
Tax
−1
—
−31
−118
−71
Net profit
6
−12
109
453
497
Balance sheet
SEK thousands
Item
2026
2025
2024
2023
2022
Total assets
1 418
1 645
1 907
2 126
1 894
Equity
1 287
1 490
1 707
1 793
1 527
Long-term debt
—
—
—
—
—
Short-term debt
17
16
62
194
228
Total debt
17
16
62
194
228
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2022
2026
Equity ratio
90,7 %
This company
38,2 %
Market median
This company
Market median
137% above market
2022
2026
Return on equity
0,5 %
This company
18,4 %
Market median
This company
Market median
97% below market
2022
2026
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2022
2026
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2022
2026
Debt / equity
0,10×
This company
0,62×
Market median
This company
Market median
84% below market
2022
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-05-01 – 2026-04-30
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
More on BioTech Development in Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
